APP and Alzheimer disease: Recent evidence, particularly from studies using APP/PS1 AD transgenic mouse models, suggests that long-term exposure (five weeks) to high doses (13–18 g/kg) of alcohol can induce cognitive impairments and enhance the enzymatic activity of BACE1 and γ-secretase involved in APP processing.